首页> 外文OA文献 >Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies

【2h】

Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies

机译：甘氨吡咯醛酸盐/福莫特罗富马酸富马酸盐计量吸入器（GFF MDI）在改善肺功能下降低患者的恶化，中度至极其严重的COPD患者的益处：对脊柱研究的汇总分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Fernando J. Martinez; Brian J. Lipworth; Klaus F. Rabe; David J. Collier; Gary T. Ferguson; Sanjay Sethi; Gregory J. Feldman; Gerald O’Brien; Martin Jenkins; Colin Reisner;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies [J] . Fernando J. Martinez, Brian J. Lipworth, Klaus F. Rabe, Respiratory Research . 2020,第1期

机译：甘氨吡咯醛酸盐/福莫特罗富马酸富马酸盐计量吸入器（GFF MDI）在改善肺功能下降低患者的恶化，中度至极其严重的COPD患者的益处：对脊柱研究的汇总分析
2. Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies [J] . Fernando J Martinez, Klaus F Rabe, Brian J Lipworth, International Journal of Chronic Obstructive Pulmonary Disease . 2020,第1期

机译：甘氨瓶/福莫特罗富马酸核苷酸计量剂量吸入器改善了肺功能与黄金类别中的单一医疗，COPD患者：汇集了第三阶段Pinnacle研究的数据
3. Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA [J] . Brian J Lipworth, David J Collier, Yasuhiro Gon, International Journal of Chronic Obstructive Pulmonary Disease . 2018,第1期

机译：在COPD中采用共同悬浮输送技术改善了肺功能并向患者报告了结果，其中所述的COPD吸入剂是复方格隆溴铵/福莫特罗富马酸盐计量吸入器：一项在亚洲，欧洲和美国进行的随机III期研究
4. Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies [O] . Fernando J. Martinez, Brian J. Lipworth, Klaus F. Rabe, 2020

机译：复方格隆溴铵/福莫特罗富马酸酯计量吸入器（GFF MDI）在改善中度至非常重度COPD患者的肺功能和减少急性发作方面的益处：PINNACLE研究的汇总分析
5. Improvements in Lung Function with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Patients with COPD: A Sub-Study of the ETHOS Trial [O] . K.F. Rabe, F.J. Martinez, D. Singh, 2020

机译：肺功能的改善肺功能/甘氨吡咯烷酯/甲酚富马酸莫酸酯剂量吸入器（BGF MDI）与COPD患者的双重疗法：ETHOS试验的分析

Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies

著录项

引文网络

相似文献

相关主题

期刊订阅